Template:Seizure actively seizing management: Difference between revisions
Ostermayer (talk | contribs) No edit summary |
Neil.m.young (talk | contribs) (Changed order of meds per 2016 guidelines) |
||
| Line 4: | Line 4: | ||
#*Ensure clear airway after seizure stops | #*Ensure clear airway after seizure stops | ||
#[[Benzodiazepine]] | #[[Benzodiazepine]] | ||
#* | #*Initial therapy of choice<ref>Glauser T, et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American Epilepsy Society. Epilepsy Curr. 2016; 16(1):48-61.</ref> | ||
#**[[Midazolam]] IM 10mg (>40kg), 5mg (13-40kg), or 0.2mg/kg<ref>McMullan J, Sasson C, Pancioli A, Silbergleit R: Midazolam versus diazepam for the treatment of status epilepticus in children and young adults: A meta-analysis. Acad Emerg Med 2010; 17:575-582</ref> | |||
#**[[Midazolam]] IM 0.2mg/kg<ref>McMullan J, Sasson C, Pancioli A, Silbergleit R: Midazolam versus diazepam for the treatment of status epilepticus in children and young adults: A meta-analysis. Acad Emerg Med 2010; 17:575-582</ref> | #**[[Lorazepam]] IV 2mg or 0.1mg/kg | ||
#**[[Diazepam]] PR 0. | #**[[Diazepam]] IV 0.15-0.2mg/kg (up to 10mg) | ||
#*Alternatives | |||
#**[[Diazepam]] PR 0.2-0.5mg/kg (up to 20mg) | |||
#**[[Midazolam]] PN or Buccal | |||
#Secondary medications | #Secondary medications | ||
#*[[ | #*[[Fosphenytoin]] 20-30mg/kg/PE at 150mg/min | ||
#**Contraindicated in pts w/ 2nd or 3rd degree AV block | |||
#** | #**May be given IM | ||
#**[[ | #*[[Valproic acid]] IV 20-40mg/kg at 5mg/kg/min | ||
#**[[ | #*[[Levetiracetam]] IV 60mg/kg, max 4500mg/dose | ||
#*[[Phenobarbital]] IV 20mg/kg at 50-75mg/min (be prepared to intubate) | |||
#Refractory medications | #Refractory medications | ||
#*[[Propofol]] 2-5mg/kg, then infusion of 2-10mg/kg/hr OR | #*[[Propofol]] 2-5mg/kg, then infusion of 2-10mg/kg/hr OR | ||
#*[[Midazolam]] 0.2mg/kg then inusion of 0.05-2mg/kg/hr OR | #*[[Midazolam]] 0.2mg/kg then inusion of 0.05-2mg/kg/hr OR | ||
#*[[Ketamine]] 1.5mg/kg then 0.01-0.05mg/kg/hr | #*[[Ketamine]] 1.5mg/kg then 0.01-0.05mg/kg/hr | ||
#* | #*Anesthesia consult for inhaled anesthetics in OR for refractory status epilepticus<ref>Mirsattari SM et al. Treatment of refractory status epilepticus with inhalational anesthetic agents isoflurane and desflurane. Arch Neurol. 2004 Aug;61(8):1254-9.</ref> | ||
#Consider | #Consider | ||
#*Secondary causes of seizure (e.g. [[hyponatremia]], hypoglycemia, [[INH Toxicity, [[ecclampsia]]) | #*Secondary causes of seizure (e.g. [[hyponatremia]], hypoglycemia, [[INH Toxicity, [[ecclampsia]]) | ||
#*EEG to rule-out nonconvulsive status | #*EEG to rule-out nonconvulsive status | ||
#*Prophylactic intubation | #*Prophylactic intubation | ||
Revision as of 15:13, 9 March 2016
- Protect patient from injury
- If possible place patient in left lateral position to reduce risk of aspiration
- Do not place bite block
- Ensure clear airway after seizure stops
- Benzodiazepine
- Secondary medications
- Fosphenytoin 20-30mg/kg/PE at 150mg/min
- Contraindicated in pts w/ 2nd or 3rd degree AV block
- May be given IM
- Valproic acid IV 20-40mg/kg at 5mg/kg/min
- Levetiracetam IV 60mg/kg, max 4500mg/dose
- Phenobarbital IV 20mg/kg at 50-75mg/min (be prepared to intubate)
- Fosphenytoin 20-30mg/kg/PE at 150mg/min
- Refractory medications
- Consider
- Secondary causes of seizure (e.g. hyponatremia, hypoglycemia, [[INH Toxicity, ecclampsia)
- EEG to rule-out nonconvulsive status
- Prophylactic intubation
- ↑ Glauser T, et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American Epilepsy Society. Epilepsy Curr. 2016; 16(1):48-61.
- ↑ McMullan J, Sasson C, Pancioli A, Silbergleit R: Midazolam versus diazepam for the treatment of status epilepticus in children and young adults: A meta-analysis. Acad Emerg Med 2010; 17:575-582
- ↑ Mirsattari SM et al. Treatment of refractory status epilepticus with inhalational anesthetic agents isoflurane and desflurane. Arch Neurol. 2004 Aug;61(8):1254-9.
